Tagged Articles

metabolic syndrome 5 articles

Blood sugar increases with statins a concern for diabetics

Type 2 diabetes increases the risk of heart attacks and strokes. Many patients with diabetes also have elevated cholesterol levels – a condition that can also increase cardiovascular risks – which is often managed by cholesterol-lowering statin medications. However, recent studies show that statin therapy can increase blood sugar levels. Statin medications, such as the widely prescribed Lipitor, reduce the number of cardiovascular events overall, but have also been shown to increase fasting blood glucose and HbA1c, a form of hemoglobin that is measured primarily to identify the average blood glucose concentration over a prolonged period of time. New studies ... Read More

Diet pill Qsymia may reduce risk of type 2 diabetes in obese patients

Obese patients who took the new weight loss drug Qsymia were more than 70 percent less likely to develop type 2 diabetes compared to patients who were taking a placebo, according to a late-stage clinical trial. Type 2 diabetes is a chronic condition in which the body does not produce any or enough insulin, causing unstable blood sugar levels. Being overweight significantly increases the risk of developing the disease. Qsymia was approved last year and became the first weight loss pill to be approved for sale in the United States in 13 years. The drug is intended for people with a ... Read More

Statins help lower stroke risk in diabetics, but can increase risk of diabetes in others

Cholesterol-lowering statin medications reduce the risk of recurrent stroke in patients who have diabetes or metabolic syndrome, a group of risk factors that occur together and increase the risk for coronary artery disease, stroke and type 2 diabetes, a new analysis indicates. The study, conducted by researchers at Vanderbilt University, is the first that focuses on the effect of statin treatment on secondary stroke prevention in people with type 2 diabetes or metabolic syndrome. The primary conclusion of the clinical trial found that the statin Lipitor (atorvastatin) reduced the risk of stroke in general. The secondary analysis assessed stroke risk ... Read More

Binge drinking may increase risk for type 2 diabetes

Knocking back way too many festive beverages causes insulin resistance, which can lead to type 2 diabetes, tests on lab rats reveals. The research is the first that links binge drinking alone – apart from other factors such as overeating – to an increase in the risk of developing the chronic illness. Before this study, it was unknown whether binge drinking alone caused metabolic syndrome and type 2 diabetes. But researchers at the Diabetes Obesity and Metabolism Institute at the Icahn School of Medicine at Mount Sinai in New York say they have some answers. Alcohol appears to disrupt insulin-receptor ... Read More

Actos for depression puts more at risk for bladder cancer

A new study shows that the type 2 diabetes drug Actos (pioglitazone) has been shown to be an effective treatment for major depressive disorder (MDD), but does this benefit outweigh its risk for cancer? Actos is in a class of medications known as thiazolidinediones (TZDs), or glitazones, medications used to treat type 2 diabetes. Other drugs in this class include Avandia (rosiglitazone) and Rezulin (troglitazone). TZDs have shown to help relieve depression symptoms in animal studies and in uncontrolled studies evaluating with people who have MDD and metabolic syndrome, including type 2 diabetes. While these drugs are insulin sensitizers, they also have ... Read More